Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897962 · ClinicalTrials.gov registry record
Blood Glycan Biomarkers in Women With Stage IV Breast Cancer
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 163
- Enrollment target
NCT00897962: Completed study, sponsored by University of California, Davis.
NCT00897962 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 163 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897962 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood glycan biomarkers in women with stage IV breast cancer.
Interventions
- OTHER Healthy Controls
- OTHER Metastatic Breast Cancer
- OTHER Non-cancer medical illness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2006-09 |
| Est. Completion | 2016-01-12 |
What the finished NCT00897962 record still lists
NCT00897962 is an observational study that tracks outcomes without assigning an intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Healthy Controls is the first listed.
NCT00897962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897962 about?
NCT00897962 is a clinical study titled "Blood Glycan Biomarkers in Women With Stage IV Breast Cancer". RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood glycan biomarkers in women with stage IV breast cancer.
What is the current status of trial NCT00897962?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2006-09. Estimated completion is 2016-01-12.
What interventions are being tested in trial NCT00897962?
The interventions under investigation include: Healthy Controls (OTHER), Metastatic Breast Cancer (OTHER), Non-cancer medical illness (OTHER).
Who is sponsoring clinical trial NCT00897962?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia